PRRT2 and cardiac hypertrophy: Later on, altered levels and activation of PKC, especially isoforms α, β, δ and ε, in hypertrophied and failed hearts supported the role of PKC in cardiac hypertrophy (Gu and Bishop, 1994; Bowling et al., 1999; Simonis et al., 2007).